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In 2005, the World Health Organization (WHO) launched 
the International Clinical Trials Registry Platform (ICTRP) 
project to set international norms and standards for 
clinical trial registration and reporting. Registering tri-
als at inception in an international registry and making 
them publicly accessible offers many benefits, including: 
(i) guarding against the threat of suppressing negative 
findings and exaggerating positive ones;1 (ii) prevent-
ing duplication of effort by improving transparency;2,3 
(iii) avoiding misleading conclusions being drawn from 
forms of care that are most likely to benefit patients;4 
and (iv) identifying research gaps that should be ad-
dressed in future trials. Registries of clinical trials also 
provide an important mechanism by which members of 
the public can learn of ongoing and completed trials and 
that may positively influence their participation in such 
trials as an opportunity to contribute to research.5
In support of a comprehensive approach to public regis-
tration and reporting of clinical trials, the International 
Committee of Medical Journal Editors (ICMJE) stipulated 
that all trials commencing enrolment after 1 July 2005 
would be published in ICMJE member journals only if 
they had been registered with an appropriate repository.5 
A number of publicly accessible registries of clinical trials 
are currently available to meet various specific needs,6 
the two major ones being ClinicalTrials.gov, run by the 
USA’s National Library of Medicine, and the metaReg-
ister of Controlled Trials (mRCT), established by Current 
Controlled Trials.7 ClinicalTrials.gov provides information 
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Introduction. Researchers, practitioners and policymakers make decisions at all levels – from local to international. 
Accessible, integrated and up-to-date evidence is essential for successful and responsive decision-making. A cur-
rent trials register of randomised and clinically controlled trials of HIV/AIDS interventions can provide invaluable 
information to decision-making processes. Using the newly emerging geographical information systems (GIS) 
technology, we have developed a tool which assists such decisions.
Objective. To demonstrate how the tool provides consistent, quantitative information in an accessible format, mak-
ing it a key tool in evidence-based decision-making.
Methods. We identified all HIV/AIDS trials in relation to publications for the period 1980 - 2007, using both elec-
tronic and manual search methods. To facilitate searching the trials register, studies were coded by using a com-
prehensive but user-friendly coding sheet. We captured the geographical co-ordinates for each trial and used the 
ArcGIS 9 mapping software to design and develop a geodatabase of trials.
Results. The geodatabase delivered the complete requirements for a data-driven information system, featuring 
the following functions: (i) a clear display of the spatial distribution of HIV/AIDS trials around the world; (ii) iden-
tification of and access to information about any particular trial on a map; and (iii) a global resource of potential 
information on the safety and efficacy of prevention and treatment measures.
Conclusions. The building of a functioning HIV/AIDS trials management system can provide policymakers, re-
searchers and practitioners with accessible, integrated and up-to-date evidence that is essential to successful and 
dynamic decision-making.
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about registered trials including: a summary of the pur-
pose of the study; eligibility criteria; trial location; study 
design; trial phase; disease or condition; and drug or 
therapy under study. Trials registered on the mRCT re-
ceive a unique number (the International Standard Ran-
domized Controlled Trial Number (ISRCTN)), which helps 
to eliminate double registering and allows a trial to be 
tracked and identified throughout its life cycle.8  In addi-
tion to the ISRCTN, mRCT lists the following information 
about each trial: title; sponsor; disease or condition un-
der study; hypothesis and objectives; eligibility; current 
status; and contact information.5
In this paper, we present the methods employed by the 
Cochrane HIV/AIDS Review Group (CRG) in developing 
an HIV/AIDS trials management system (HTMS), coupling 
GIS technology and a relational database management 
system to locate HIV/AIDS randomised clinical trials 
(RCTs) and controlled clinical trials (CCTs) throughout 
the world.
A GIS is a system of computer software and hardware, 
data and personnel that makes it possible to enter, ma-
nipulate, analyse, and present spatially referenced infor-
mation, i.e. information tied to a locus on the earth’s 
surface.9 Several authors have described the applications 
of GIS in the area of public health.10-14 In the past decade, 
however, the scope of GIS and health policy and practice 
has risen to prominence, and researchers, practitioners 
and policymakers are recognising that the GIS tool can 
facilitate efficient and effective decision-making. This 
paper presents the features of the HTMS and demon-
strates, with an example of the application, how the sys-
tem can support decisionmakers.
IdentIfIcatIon of trIals
The HTMS consists of two components: the first involves 
the identification of HIV/AIDS trials from electronic 
bibliographic database sources which include PubMed/
MEDLINE, EMBASE, and AIDSearch, as well as from 
‘hand searching’ non-indexed journals and conference 
proceedings. The included studies are all RCTs and CCTs 
evaluating the efficacy or effectiveness of preventing or 
treating HIV/AIDS and related conditions. Trials which 
assess interventions that may have an effect on HIV 
transmission (e.g. condom use) are included, but those 
trials assessing interventions specific to other sexually 
transmitted infections are excluded, as are trials which 
only assess safety (so-called phase I trials).
All identified trials are imported into a study-based reg-
ister in MeerKat, an in-house bibliographic management 
software package built in Microsoft Access and devel-
oped by the international organisation, the Cochrane 
Collaboration (CC).15 Owing to the relational nature of 
the database, different fields can be related to each 
other, allowing references, studies, reviews and authors 
to be interlinked. To facilitate searching in the trials reg-
ister, the studies are coded, using a comprehensive and 
user-friendly coding sheet. Table I lists the required data 
elements for the coding sheet.
The study name is a unique text assigned to each 
trial, and is usually the last name of the first author 
followed by the publication year, e.g. Brown 2006. 
For any subsequent publications by the same 
author in the same year, the trial is assigned the study 
name Brown1 2006, Brown2 2006, etc. The status of 
the study gives an indication of whether the trial is 
closed, ongoing, planned or was stopped early. Study 
design types include RCT, CCT or systematic review 
(a study type which compiles and pools the data of RCT 
results of a particular intervention). The register status 
reveals whether a particular trial is pending, accepted 
or rejected. Other data elements such as intervention, 
outcomes and the ISRCTN are also captured. Free fields 
are available to capture additional information when 
specific elements of trials are being studied, such as 





  Closed Open/Ongoing Planned Stopped early
Design
  RCT CCT  Systematic review 
Register status








table I. data eleMents for tHe codInG sHeet
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To facilitate the mapping process, we capture the loca-
tion of the trial in terms of latitude and longitude. For 
multi-centre trials, the geographical co-ordinates of 
each centre are recorded. The coding sheet mirrors the 
user-friendly input screens of the register (Fig. 1). Fields 
contain drop-down lists from which items have to be 
selected, to avoid typing errors.
InteGratIon of tHe reGIster Into GIs
The second component involves implementing the GIS 
platform of the HTMS. Using the Environmental Systems 
Research Institute family of software known as ArcGIS 9, 
we created a new geodatabase in ArcCatalog, which in-
volved integrating the trials register in MeerKat (Micro-
soft Access) with a series of GIS map layers. The datasets 
included continents and countries’ boundaries. The long-
itude and latitude of each study identifies the X and Y 
spatial co-ordinates in geographical space. This allowed 
us to map the geographical location of each study.
To date, the database contains 7 382 records relating 
to publications in the years 1980 - 2007, and is being 
updated quarterly, continually coded and regularly qual-
ity-controlled by random checks of the data. The archi-
tecture of the HTMS is shown in Fig. 2.16
spatIal dIstrIbutIon of trIals
The spatial distribution of HIV/AIDS trials across the 
world is clearly displayed. For example, spatially distrib-
uting a convenience sample of 53 trials from the year 
2003 showed that 50 of these were RCTs and 3 were 
CCTs (Fig. 3). Further analysis carried out by compiling a 
report (Fig. 4) or chart (Fig. 5) indicated the number of 
trials conducted on each continent.
IdentIfIcatIon of trIals
The system provides a foundation and suite of tools for 
monitoring and tracking ongoing, completed and pub-
lished trials and their characteristics.  When the user 
clicks on a particular trial, the resulting window displays 
all attributes of the trial, as shown in Fig. 6.
results
Fig. 1. Input screen of the register.
Fig. 2. Architecture of the HTMS.
Fig. 3. Spatial distribution of 50 RCTs and 3 CCTs from the year 
2003.
Fig. 4. Report output.
Fig. 5. Graph output.
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QueryInG tHe HtMs
The Find button facilitates searching the HTMS. Because 
the trials are coded in different ways, as shown in Table 
I, locating treatment trials can be done by typing ‘treat-
ment’ in the Find search box, selecting ‘tbltrials’ from the 
In drop-down menu list, selecting ‘intervention’ from 
the In fields drop-down menu list, and finally clicking on 
Find. The Find dialogue box will then list all intervention 
trials, as shown in Fig. 7, and, on double-clicking, that 
selected will be highlighted on the active map.
The need for comprehensive, up-to-date and easily acces-
sible trials registers has been recognised for years. In the 
last two years, we have designed and implemented a sys-
tem which offers an infrastructure of support to research-
ers, practitioners and policymakers, with up-to- date and 
reliable trials that satisfies the right of all children and 
adults to have access to all the available evidence regard-
ing HIV/AIDS trials. The geodatabase developed in this 
work is a comprehensive source of clinical information 
obtained by searching electronic bibliographic sources as 
well as hand searching non-indexed journals and confer-
ence proceedings. The compilation of the HTMS serves the 
purpose of continual identification and data warehousing 
of HIV/AIDS trials across the world.
In addition, the HTMS is a landmark initiative in tracking 
and monitoring HIV/AIDS RCTs and CCTs in global health 
research endeavours. Instead of depending solely on in-
formation in text format, the visual synthesis of informa-
tion into a picture and the overlay of quantitative graphics 
allow users of the system to realise the spatial distribution 
of the trials across the world in a clear manner. The sys-
tem presented here can be used for trials characterisation 
and also serve as a valuable source of information for re-
searchers as they initiate and design their studies. Another 
strength of the system is its ability to act as a research 
tool for analysing trends in the conduct of trials around 
the globe. For example, since sub-Saharan Africa carries 
the heaviest burden of the HIV/AIDS pandemic, research-
ers can follow in a timely and detailed way the location 
of trials conducted in this region, which can provide both 
an historical tracking system as well as identifying gaps 
where HIV/AIDS prevalence is high but clinical interven-
tion research is lacking.
As much as the HTMS has several success factors, it 
also has its share of limitations. The HTMS is only as 
good as the data it contains; it is currently being up-
dated and maintained by a single person, with support 
from a number of trial coders. Populating the HTMS is 
a labour-intensive process and entails a conscientious 
effort which includes downloading records from elec-
tronic bibliographic sources, followed by the necessary 
formatting, configuration and de-duplication of records 
prior to importing them into the register. The challenge 
is to continually monitor and improve the quality of the 
records and ensure that they are coded in the correct 
coding categories as shown in Table I. The currency of 
the information in the trials bank is of great importance, 
and the accuracy and completeness of the data are 
critical so that the maps communicate effectively and 
inform the broad range of users who may view them 
without misinformation.
The register put together by ClinicalTrials.gov (http://
www.clinicaltrials.gov/ct/action/GetStudy) also offers 
a geographical perspective of clinical trials and allows 
website visitors to click on a region to display studies 
with locations in that region. However, ClinicalTrials.gov 
lists trials that are currently under way, meaning that 
the register is a prospective one whilst the HTMS is ret-
rospective and contains all HIV/AIDS RCTs and CCTs since 
1980, including the human T-lymphotropic virus type III 
(HTLV III) trials, as HIV was commonly referred to before 
1985. The African Clinical Trials Portal (http://www.afri-
caclinicaltrials.org/) is yet another comprehensive online 
resource for easily accessible information on malaria, 
HIV/AIDS and TB clinical trials in Africa. The portal is a 
one-stop resource that allows users to access clinical 
trial information using a database of pre-licensure clini-
cal trials of malaria, HIV/AIDS and TB drugs, vaccines and 
microbicides that are currently under way in Africa. 
Similarly to ClinicalTrials.gov, the African Clinical Trials 
Portal is a prospective register where data manipulation 
dIscussIon and conclusIon
Fig. 6. Table of attributes.
Fig. 7. Querying the HTMS.
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at the user end is restricted. To our knowledge, the HTMS 
is the first retrospective compilation of HIV/AIDS trials 
around the world. As the information technology revo-
lution (including online systems), the World Wide Web, 
and other electronic information systems continue to 
expand both the volume and accessibility of informa-
tion,17 the next component of this project will involve 
translating the desktop HTMS into a web-based HTMS 
to publicly make available all the clinical trials infor-
mation. Within the web-based system, multiple users 
from different locations will only require their existing 
web browser to view geographical data and access the 
trials-related data, without the requirements or costs of 
installing GIS software packages.
With the implementation of the international HTMS, the 
need to communicate HIV/AIDS trials-related data to re-
searchers, practitioners and policymakers has begun to 
be achieved as it proves to be an effective information-
gathering and management tool. Our plans to make the 
data available online will increase the accessibility of the 
information. Ultimately, we hope that policymakers and 
researchers will find the HTMS a transparent means of 
capturing trial information so that all trial results are 
available to all parties involved – including consumers 
and their carers. In the future, the use of GIS technol-
ogy could be regarded as a means of facilitating access 
to evidence-based health care data and contributing to 
policy development.
We are grateful to the Cochrane HIV/AIDS Review Group 
and the South African Cochrane Centre for funding the 
HIV/AIDS Trials Management System. We are especially 
grateful to George Rutherford, Gail Kennedy, Tara Hor-
vath and Jimmy Volmink for their ongoing support of, 
and belief in, the mapping project described in this paper. 
Our thanks also go to the tireless data coders, Joy Oliver, 
Elizabeth Pienaar, Jenny Burton and Don Operario.
REFERENCES
  1.  Abbasi K. Compulsory registration of clinical trials. BMJ 2004; 329: 637-638.
  2.  Tonks A. Registering clinical trials. BMJ 1999; 319: 1565-1568.
  3.  Krleza-Jeric K, Chan A, Dickersin K, Sim I, Grimshaw J, Gluud C. Principles 
for international registration and results from human trials of health related 
interventions: Ottawa statement (part 1). BMJ 2005; 330: 956-958.
  4.  Faure H. In Mayor S. New register will track trials funded by the NHS. BMJ 2003; 
327: 1010.
  5. Gold JL, Studdert DM. Clinical trials registries: a reform that is past due. J Law 
MedEthics 2005; 33(4): 811-820.
  6.  Krleza-Jeric K. Clincial trialr: the differing views of industry, the WHO and the 
Ottawa Group. PloS Med 2005; 2(11): e378.
  7.  Dickersin K, Rennie D. Registering clinical trials. JAMA 2003; 290: 516-523.
  8.  WHO: International Clinical Trials Registry Platform. Geneva: World Health 
Organization. http://www.who.int/ictrp/en (accessed 18 May 2006).
  9.  Geographic Information Systems Learning Laboratory: What is GIS? http://webpub.
allegheny.edu/dept/envisci/GISLab/whatisgis01b.htm (accessed 10 June 2005).
10.  Moore DA, Carpenter TE. Spatial analytical methods and geographic information 
systems: Use in health research and epidemiology. Epidemiol Rev 1999; 21(2), 143-
161.
11.  Jerrett M, Burnett R, Golberg M, et al. Spatial analysis for environmental health 
research concepts, methods, and examples. J Toxicol Environ Health Part A 2003; 
66: 1783-1810.
12.  Selvin S, Merrill DW, Erdmann C, White M, Ragland K. Breast cancer detection: maps 
of 2 San Francisco bay area counties. Am J Public Health 1998; 88: 1186-1192.
13.  Shuai J, Buck P, Sockett P, Aramini J, Pollari F. A GIS-driven integrated real-time 
surveillance pilot system for national West Nile virus dead bird surveillance in 
Canada. Int J Health Geographics 2006; 5: 17.
14.  Richards TB, Croner CM. Geographic information systems and public health: 
mapping the future. Public Health Reports 1999; 114(4): 359-361.
15.  MeerKat. http://www.cc-ims.net/Projects/MeerKat/ (accessed 13 October 2006).
16.  Busgeeth K, Rivett U. The use of a spatial information system in the management 
of South Africa. Int J Health Geographics 2004; 3: 13.
17.  Riner ME, Cunningham C, Johnson A. Public health education and practice using 
geographic information system technology. Public Health Nurs 2004; 21(1): 57-65.
562
pg58-62.indd   62 6/20/08   9:37:20 AM
Specialists& GP’s Registrars
Early Late Early Late
Full Registration R950 R1100 R550 R650






The University of the Witwatersrand, Faculty of
Health
Sciences, Department of Internal Medicine invites
you to attend their Annual Update Meeting.
The aim of the Update is to bring Specialist
Physicians,
General Practitioners and Registrars up to speed
on
Exciting Topics to be covered:
The Arthur Landau Memorial Lecture: Phaeochromocytoma -
Tumour Extraordinaire; State-of-the-art lectures on various
conditions within the spectrum of Internal Medicine
Contact Details:
Jean Johnstone:






University of the Witwatersrand,
Parktown 2193
Accommodation:
Available at the Sunnyside Park Hotel—
For rates and further information please contact Jean
Untitled-3   1 6/19/08   4:11:16 PM
